Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection Post author:Sam Post published:August 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Aptinyx Bags $70M Financing to Fuel Expanding Pipeline December 17, 2017 Boy Wonder Roivant Bets $116 Million on Arbutus October 1, 2017 FDA Gives Go-Ahead for Tetra's Phase II Trial March 15, 2018